Is this you? Create Your Porfile
Avatar

Franck Halley

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Franck Halley is active.

Explore More

Publication

Featured researches published by Franck Halley.

Archive | 2003

Pyridazinone derivatives as gsk-3beta inhibitors

Swen Hoelder; Thorsten Naumann; Karl Schoenafinger; David William Will; Hans Matter; Guenter Mueller; Suisse Dominique Le; Bernard Baudoin; Thomas Rooney; Franck Halley; Gilles Tiraboschi

Archive | 2003

Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same

Dominique Lesuisse; Gilles Dutruc-Rosset; Franck Halley; Didier Babin; Thomas Rooney

Archive | 2003

Pyridazinone derivatives as cdk2-inhibitors

Swen Hoelder; Thorsten Naumann; Karl Schoenafinger; David William Will; Hans Matter; Guenter Mueller; Suisse Dominique Le; Bernard Baudoin; Thomas Rooney; Franck Halley; Gilles Tiraboschi; Cécile Combeau; Ingrid Sassoon; Anke Steinmetz

Archive | 2003

Aminoindazole derivatives as medicaments and pharmaceutical compositions including them

Dominique Lesuisse; Gilles Dutruc-Rosset; Franck Halley; Didier Babin; Thomas Rooney; Gilles Tiraboschi

Archive | 2003

Aminoindazole derivatives and use thereof as kinase inhibitors

Dominique Lesuisse; Gilles Dutruc-Rosset; Franck Halley; Didier Babin; Thomas Rooney; Gilles Tiraboschi

Archive | 2005

Substituted indazoles, compositions containing same, preparation and use

Franck Halley; Michel Tabart; Herve Bouchard; Catherine Souaille; Brun Alain Le; Fabrice Viviani; Laurence Gauzy-Lazo; Pascal Desmazeau; Odile Angouillant-Boniface; Bruno Filoche-Romme

Archive | 2002

New 4-(carboxamido or acylamino)-6-(hetero)aryl-pyridazinone derivatives are tau-protein phosphorylation inhibitors useful e.g. for treating neurodegenerative diseases, diabetes, hypertension or cancer

Dominique Lesuisse; Franck Halley; Bernard Baudoin; Thomas Rooney; Swen Hoelder; Thorsten Naumann; Gilles Tiraboschi

Archive | 2003

Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them

Swen Hölder; Thorsten Naumann; Karl Schönafinger; David William Will; Hans Matter; Günther Müller; Dominique Le Suisse; Bernard Baudoin; Thomas Rooney; Franck Halley; Gilles Tiraboschi; Cécile Combeau; Ingrid Sassoon; Anke Steinmetz

Archive | 2003

Derives d’aminoindazoles comme inhibiteurs de proteine-kinase

Gilles Dutruc-Rosset; Dominique Lesuisse; Thomas Rooney; Franck Halley

Archive | 2003

Aminoindazole derivatives as protein-kinase inhibitors

Gilles Dutruc-Rosset; Dominique Lesuisse; Thomas Rooney; Franck Halley

Explore More

Collaboration

Dive into the Franck Halley's collaboration.

Top Co-Authors
Avatar

Thomas Rooney

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gilles Dutruc-Rosset

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Gilles Tiraboschi

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Bernard Baudoin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Didier Babin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Thorsten Naumann

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

David William Will

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Swen Hoelder

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Guenter Mueller

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Karl Schoenafinger

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge